Serum levels of soluble CD26 and CD30 and their clinical significance in patients with rheumatoid arthritis

被引：21

作者：

Ulusoy, Hasan ^{[1
]}

Kamanli, Ayhan ^{[1
]}

Ilhan, Necip ^{[2
]}

Kuru, Omer ^{[3
]}

Arslan, Sule ^{[4
]}

Alkan, Gokhan ^{[1
]}

Ozgocmen, Salih ^{[5
]}

机构：

[1] Firat Univ, Fac Med, Dept Phys Med & Rehabil, Div Rheumatol, TR-23169 Elazig, Turkey

[2] Firat Univ, Dept Biochem, Fac Med, TR-23169 Elazig, Turkey

[3] Ondokuz Mayis Univ, Fac Med, Dept Phys Med & Rehabil, Div Rheumatol, Samsun, Turkey

[4] Gaziosmanpasa Univ, Fac Med, Dept Phys Med & Rehabil, Tokat, Turkey

[5] Erciyes Univ, Gevher Nesibe Hosp, Dept Phys Med & Rehabil, Div Rheumatol,Sch Med, Kayseri, Turkey

来源：

RHEUMATOLOGY INTERNATIONAL | 2012年 / 32卷 / 12期

关键词：

Rheumatoid arthritis; Disease activity; CD26; CD30; DIPEPTIDYL-PEPTIDASE-IV; CD4(+) T-CELLS; SYNOVIAL-FLUID; DISEASE-ACTIVITY; FUNCTIONAL-ROLE; EXPRESSION; INFLAMMATION; CYTOKINES; OSTEOARTHRITIS; PATHOGENESIS;

D O I：

10.1007/s00296-011-2302-3

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

The aim of this study was to assess serum levels and clinical significance of soluble CD26 (sCD26) and soluble CD30 (sCD30) in patients with rheumatoid arthritis (RA). Forty-eight patients with RA and 30 healthy controls were enrolled. Serum sCD26 and sCD30 levels were measured using ELISA. Serum sCD26 levels were significantly lower (P = 0.011), whereas sCD30 levels were higher (P = 0.008) in patients with RA than controls. Serum levels of sCD30 correlated significantly with clinical and laboratory parameters of disease activity like erythrocyte sedimentation rate, C-reactive protein, disease activity scores-28 and health assessment questionnaire score; however, sCD26 levels did not correlate any of these activity parameters. These results suggest that serum sCD30 levels increased and correlated significantly with disease activity, indicating a novel follow-up parameter in RA. Serum levels of sCD26 may be lessen but not related to disease activity in RA.

引用

页码：3857 / 3862

页数：6

共 40 条

[11] Role of CD30+ T cells in rheumatoid arthritis:: a counterregulatory paradigm for Th1-driven diseases [J].

Gerli, R ;

Lunardi, C ;

Vinante, F ;

Bistoni, O ;

Pizzolo, G ;

Pitzalis, C .

TRENDS IN IMMUNOLOGY, 2001, 22 (02) :72-77

[12]

Gerli R, 1995, CLIN EXP IMMUNOL, V102, P547

[13] Soluble CD30 in early rheumatoid arthritis as a predictor of good response to second-line therapy [J].

Gerli, R ;

Bistoni, O ;

Lunardi, C ;

Giacomelli, R ;

Tomassini, C ;

Biagini, P ;

Pitzalis, C .

RHEUMATOLOGY, 1999, 38 (12) :1282-1284

[14] CD30+ T cells in rheumatoid synovitis:: Mechanisms of recruitment and functional role [J].

Gerli, R ;

Pitzalis, C ;

Bistoni, O ;

Falini, B ;

Costantini, V ;

Russano, A ;

Lunardi, C .

JOURNAL OF IMMUNOLOGY, 2000, 164 (08) :4399-4407

[15]

Gerli R, 2001, IMAJ S, V4, P949

[16]

GERLI R, 2001, RRD ALL CLIN IMMUNOL, V2, P79

[17] CD26: A multifunctional integral membrane and secreted protein of activated lymphocytes [J].

Gorrell, MD ;

Gysbers, V ;

McCaughan, GW .

SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2001, 54 (03) :249-264

[18] Dipeptidyl peptidase IV (DP IV, CD26) in patients with inflammatory bowel disease [J].

Hildebrandt, M ;

Rose, N ;

Rüter, J ;

Salama, A ;

Mönnikes, H ;

Klapp, BF .

SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2001, 36 (10) :1067-1072

[19]

Ichikawa Y, 1998, CLIN EXP RHEUMATOL, V16, P759

[20] ACTIVITIES OF DIPEPTIDYL PEPTIDASE-II, DIPEPTIDYL PEPTIDASE-IV, PROLYL ENDOPEPTIDASE, AND COLLAGENASE-LIKE PEPTIDASE IN SYNOVIAL-MEMBRANE FROM PATIENTS WITH RHEUMATOID-ARTHRITIS AND OSTEOARTHRITIS [J].

KAMORI, M ;

HAGIHARA, M ;

NAGATSU, T ;

IWATA, H ;

MIURA, T .

BIOCHEMICAL MEDICINE AND METABOLIC BIOLOGY, 1991, 45 (02) :154-160

← 1 2 3 4 →